author-photo

Ian A. Wilson

Scripps Research Institute
International AIDS Vaccine Initiative
Scripps Health

1251

Papers

89900

Citations

Citation Trend

Filter By

Papers (1250) Sort By

Journal Conference Others

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (4)
Structural basis for differential recognition of phosphohistidine-containing peptides by 1-pHis and 3-pHis monoclonal antibodies.

2021 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (4)
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (5)
Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum.

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (5)
Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (9)
Robust de novo design of protein binding proteins from target structural information alone

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)
Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates.

2021 Science Advances
Show All
- Source
- Cite
- Save
Citations (18)
A cross-neutralizing antibody between HIV-1 and influenza virus.

2021 PLOS Pathogens
Show All
- Source
- Cite
- Save
Citations (4)
Selection of a picomolar antibody that targets CXCR2-mediated neutrophil activation and alleviates EAE symptoms.

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (1)
A large-scale systematic survey of SARS-CoV-2 antibodies reveals recurring molecular features

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)